Spectral AI Appoints Peter M. Carlson as CEO

What You Should Know:

– Spectral AI, Inc. (Nasdaq: MDAI), a leader in AI-powered wound care diagnostics, announced key leadership changes and positive financial outlooks today.

– Peter M. Carlson assumes the role of Chief Executive Officer (CEO) and joins the Board of Directors. Mr. Carlson boasts a proven track record of driving growth and financial success for multiple public companies, including experience in the wound care industry.

– Wensheng Fan, after nearly four years as CEO, transitions to Chief Innovation Strategist and Senior Advisor to the CEO. His expertise will continue to guide Spectral AI’s innovative spirit.

– Vincent S. Capone, current General Counsel and Corporate Secretary, will take on the additional responsibility of Chief Financial Officer (CFO).

Refeyn announces appointment of Fiona Coats as Chief Marketing Officer

Refeyn, the company behind pioneering mass photometry technologies, is delighted to announce the appointment of Fiona Coats as Chief Marketing Officer, effective from June, 2024.

May 22, 2024

Dexmedetomidine by Teikoku Pharma USA for Post-Operative Pain: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 8, 2023

Ultrahuman Ring AIR Lands in Verizon Stores for Health Tracking

What You Should Know: – Ultrahuman, a leader in wearable health technology announced the availability of its innovative Ultrahuman Ring AIR in select Verizon stores

August 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.